ACP Issues Advice for Assessing Patients With Suspected PE

Share this content:
ACP Issues Advice for Assessing Patients With Suspected PE
ACP Issues Advice for Assessing Patients With Suspected PE

TUESDAY, Sept. 29, 2015 (HealthDay News) -- Best practice advice on diagnosis of suspected pulmonary embolism (PE) is provided for clinicians in clinical guidelines from the American College of Physicians (ACP). The guidelines were published online Sept. 29 in the Annals of Internal Medicine.

Ali S. Raja, M.D., from Massachusetts General Hospital in Boston, and colleagues provide practical advice for the evaluation of patients with suspected acute PE based on best available evidence and recent guidelines.

The researchers note that in order to estimate pretest probability of PE, clinicians should use validated clinical prediction rules. In patients with low pretest probability of PE and who meet all PE Rule-Out Criteria, clinicians should not obtain D-dimer measurements or imaging studies. In patients with an intermediate pretest probability of PE or with a low pretest probability who do not meet all PE Rule-Out Criteria, clinicians should obtain high-sensitivity D-dimer measurement as the initial diagnostic test. For patients older than 50 years, age-adjusted D-dimer thresholds should be used. In patients with a D-dimer level below the age-adjusted cut-off, clinicians should not obtain any imaging studies. In patients with high pretest probability of PE, clinicians should obtain imaging with computed tomography pulmonary angiography.

"ACP's advice is designed to help physicians identify patients for whom a PE is so unlikely that they need no further testing, for whom plasma D-dimer testing can provide additional risk stratification, and for whom imaging is indicated because of their high risk and clinical presentation," Wayne J. Riley, M.D., M.P.H., president of the ACP, said in a statement.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »